Unlike AAV gene therapy, HSV gene therapy doesn't trigger immune responses, which means it can be dosed in perpetuity.
https://www.google.com/url?rct=j&sa=t&url=https://www.thestreet.com/investing/biotech-stocks-genetic-medicines-cystic-fibrosis&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw2edJlDkmY3YdKAvT5_BZXb
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.